Biotech / Medical : VD's Model Portfolio & Discussion Thread


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Icebrg who wrote (9507)1/30/2003 12:30:54 PM
From: Vector1Read Replies (3) of 9719
 
Iceberg,
Reasons for MLNM sale
Spending at an alarming rate
Obesity program a failure
$560m of debt coming due
IMO Velcade has less than 50% chance of approval on phase II trial. Looks desperate to me. If at end of 60 day period FDA accepts submission I may reconsider.
Integrin is a good product but modest growth ahead.
V1
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.